Notice Information
Notice Title
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B
Notice Description
National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.
Lot Information
Lot 18 - Fresh Frozen Plasma
Fresh Frozen Plasma
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 16 - Prothrombin Complex driedProthrombin Complex dried
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 15 - Fibrinogen ConcentrateFibrinogen Concentrate
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 14 - Von willebrands factor - RecombinantVon willebrands factor - Recombinant
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 17 - Protein C ConcentrateProtein C Concentrate
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 10 - Factor XIII - Plasma DerivedFactor XIII - Plasma Derived
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 11 - Factor XIII - RecombinantFactor XIII - Recombinant
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 9 - Factor XFactor X
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 8 - Factor IX - High Purity Factor IXFactor IX - High Purity Factor IX
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 7 - Factor VIII Inhibitor Bypassing FractionFactor VIII Inhibitor Bypassing Fraction
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 13 - Von willebrands factor - Plasma DerivedVon willebrands factor - Plasma Derived
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 12 - Factor VIII/ von willebrands factorFactor VIII/ von willebrands factor
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 6 - Porcine Factor VIII - susoctocog alfaPorcine Factor VIII - susoctocog alfa
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 5 - Recombinant Factor VIIRecombinant Factor VII
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 4 - rFIX - Standard Half LiferFIX - Standard Half Life
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 3 - nonacog beta pegol (rFIX EHL)nonacog beta pegol (rFIX EHL)
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 2 - albutrepenonacog alfa (rFIX EHL)albutrepenonacog alfa (rFIX EHL)
Options: Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months
Lot 1 - eftrenonacog alfa (rFIX EHL)eftrenonacog alfa (rFIX EHL)
Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-030881
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/018165-2022
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large, SME
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33141530 - Blood coagulants
Notice Value(s)
- Tender Value
- £500,000,000 £100M-£1B
- Lots Value
- £18 Under £100K
- Awards Value
- Not specified
- Contracts Value
- £1
Notice Dates
- Publication Date
- 4 Jul 20223 years ago
- Submission Deadline
- 14 Feb 2022Expired
- Future Notice Date
- Not specified
- Award Date
- 14 Jun 20223 years ago
- Contract Period
- 30 Jun 2022 - 30 Jun 2024 2-3 years
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- NHS ENGLAND
- Additional Buyers
THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Contact Name
- Philip Grieve
- Contact Email
- philip.grieve@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLE Yorkshire and The Humber
- Basic Region (ITL 2)
- TLE4 West Yorkshire
- Small Region (ITL 3)
- TLE42 Leeds
- Delivery Location
- Not specified
-
- Local Authority
- Leeds
- Electoral Ward
- Little London & Woodhouse
- Westminster Constituency
- Leeds Central and Headingley
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-030881-2022-07-04T14:02:22+01:00",
"date": "2022-07-04T14:02:22+01:00",
"ocid": "ocds-h6vhtk-030881",
"description": "RESPONDING TO THIS NOTICE:<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information<br/>This procurement exercise will be conducted on the eTendering portal at<br/>https://healthfamily.force.com/s/Welcome<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific<br/>information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidatesshould register on the eTendering portal at<br/>https://health-family.force.com/s/Welcome and<br/>click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue title to select <br/>review opportunity details and click \"Register Interest\"<br/>- as you select the opportunity, you can review documents, send clarification messages,submit the response or decline to respond (if<br/>you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis help desk at supporthealth@<br/>atamis.co.uk or by calling 0800 9956035 for technical assistance when<br/>completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to the<br/>following web page<br/>https://supplierregistration.cabinetoffice.gov.uk and select \"Register\" at the top of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S(r)Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together<br/>as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or<br/>goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare<br/>or health related services.",
"initiationType": "tender",
"tender": {
"id": "CM/PHS/19/5576",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
},
"mainProcurementCategory": "goods",
"description": "National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. The framework will commence on 1 July 2022 for a period of 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 moths. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for a list of the purchasing points.",
"value": {
"amount": 500000000,
"currency": "GBP"
},
"lots": [
{
"id": "18",
"title": "Lot 18 - Fresh Frozen Plasma",
"description": "Fresh Frozen Plasma",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "16",
"title": "Lot 16 - Prothrombin Complex dried",
"description": "Prothrombin Complex dried",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "15",
"title": "Lot 15 - Fibrinogen Concentrate",
"description": "Fibrinogen Concentrate",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "14",
"title": "Lot 14 - Von willebrands factor - Recombinant",
"description": "Von willebrands factor - Recombinant",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "17",
"title": "Lot 17 - Protein C Concentrate",
"description": "Protein C Concentrate",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "10",
"title": "Lot 10 - Factor XIII - Plasma Derived",
"description": "Factor XIII - Plasma Derived",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "11",
"title": "Lot 11 - Factor XIII - Recombinant",
"description": "Factor XIII - Recombinant",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "9",
"title": "Lot 9 - Factor X",
"description": "Factor X",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "8",
"title": "Lot 8 - Factor IX - High Purity Factor IX",
"description": "Factor IX - High Purity Factor IX",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "7",
"title": "Lot 7 - Factor VIII Inhibitor Bypassing Fraction",
"description": "Factor VIII Inhibitor Bypassing Fraction",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "13",
"title": "Lot 13 - Von willebrands factor - Plasma Derived",
"description": "Von willebrands factor - Plasma Derived",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "12",
"title": "Lot 12 - Factor VIII/ von willebrands factor",
"description": "Factor VIII/ von willebrands factor",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use 10%",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "6",
"title": "Lot 6 - Porcine Factor VIII - susoctocog alfa",
"description": "Porcine Factor VIII - susoctocog alfa",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "5",
"title": "Lot 5 - Recombinant Factor VII",
"description": "Recombinant Factor VII",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "4",
"title": "Lot 4 - rFIX - Standard Half Life",
"description": "rFIX - Standard Half Life",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "3",
"title": "Lot 3 - nonacog beta pegol (rFIX EHL)",
"description": "nonacog beta pegol (rFIX EHL)",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "2",
"title": "Lot 2 - albutrepenonacog alfa (rFIX EHL)",
"description": "albutrepenonacog alfa (rFIX EHL)",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or Options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement, including extension options, will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
},
{
"id": "1",
"title": "Lot 1 - eftrenonacog alfa (rFIX EHL)",
"description": "eftrenonacog alfa (rFIX EHL)",
"value": {
"amount": 1,
"currency": "GBP"
},
"contractPeriod": {
"startDate": "2022-07-01T00:00:00+01:00",
"endDate": "2024-06-30T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months"
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "15%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "10%"
},
{
"type": "price",
"description": "75%"
}
]
}
}
],
"items": [
{
"id": "18",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "18"
},
{
"id": "16",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "16"
},
{
"id": "15",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "15"
},
{
"id": "14",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "14"
},
{
"id": "17",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "17"
},
{
"id": "10",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "10"
},
{
"id": "11",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "11"
},
{
"id": "9",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "9"
},
{
"id": "8",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "8"
},
{
"id": "7",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "7"
},
{
"id": "13",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "13"
},
{
"id": "12",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "12"
},
{
"id": "6",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "6"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "5"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "4"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "3"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "2"
},
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33141530",
"description": "Blood coagulants"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "ITT lists Purchasing Points. F/A intended for use by the NHS in England,Scotland,Wales,Northern Ireland,Dept of Health and Social Care and Public Health England. F/A may also be used by private sector contractors and agents working on behalf of the above"
},
"relatedLot": "1"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "http://health.atamis.co.uk",
"communication": {
"atypicalToolUrl": "http://health.atamis.co.uk"
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
},
{
"id": "technical",
"documentType": "technicalSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2022-02-14T13:00:00Z"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"endDate": "2022-05-15T23:59:59+01:00"
}
},
"awardPeriod": {
"startDate": "2022-02-14T13:00:00Z"
},
"bidOpening": {
"date": "2022-02-14T13:00:00Z",
"address": {
"streetAddress": "Runcorn"
},
"description": "Commercial Medicines Unit Employee"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
}
},
"parties": [
{
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)",
"identifier": {
"legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"address": {
"streetAddress": "2nd Floor, Rutland House",
"locality": "Runcorn",
"region": "UK",
"postalCode": "WA7 2ES",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Philip Grieve",
"email": "philip.grieve@nhs.net",
"url": "http://health.atamis.co.uk"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-497",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "generaloffice@administrativecourtoffice.justice.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.gov.uk/courts-tribunals"
}
},
{
"id": "GB-FTS-3022",
"name": "NHS England",
"identifier": {
"legalName": "NHS England"
},
"address": {
"streetAddress": "Quarry House, Quarry Hill",
"locality": "Leeds",
"region": "UK",
"postalCode": "LS2 7UE",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Philip Grieve",
"email": "philip.grieve@nhs.net"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-11905",
"name": "Octapharma Limited",
"identifier": {
"legalName": "Octapharma Limited"
},
"address": {
"streetAddress": "The Zenith Building, 26 Spring Gardens",
"locality": "Manchester",
"region": "UK",
"postalCode": "M2 1AB",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd",
"identifier": {
"legalName": "CSL Behring UK Ltd"
},
"address": {
"streetAddress": "4 Milton Road, Haywards Heath",
"locality": "Haywards Heath",
"region": "UK",
"postalCode": "RH16 1AH",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd",
"identifier": {
"legalName": "Takeda UK Ltd"
},
"address": {
"streetAddress": "1 Kingdom Street",
"locality": "London",
"region": "UK",
"postalCode": "W2 6BD",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57451",
"name": "LFB",
"identifier": {
"legalName": "LFB"
},
"address": {
"streetAddress": "Suite 104, Spirella Building, Bridge Road",
"locality": "Letchworth Garden City",
"region": "UK",
"postalCode": "SG6 4ET",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57452",
"name": "Novo Nordisk",
"identifier": {
"legalName": "Novo Nordisk"
},
"address": {
"streetAddress": "3 City Place, Beehive Ring Road",
"locality": "Gatwick",
"region": "UK",
"postalCode": "RH6 0PA",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57453",
"name": "Bio Products Laboratory Ltd",
"identifier": {
"legalName": "Bio Products Laboratory Ltd"
},
"address": {
"streetAddress": "Dagger Lane, Elstree",
"locality": "Elstree",
"region": "UK",
"postalCode": "B31 2UQ",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57454",
"name": "Pfizer Ltd",
"identifier": {
"legalName": "Pfizer Ltd"
},
"address": {
"streetAddress": "Walton Oaks, Dorking Road",
"locality": "Tadworth",
"region": "UK",
"postalCode": "KT20 7NS",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-57455",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)",
"identifier": {
"legalName": "Sobi (Swedish Orphan Biovitrum Ltd)"
},
"address": {
"streetAddress": "Suite 2, Riverside 3",
"locality": "Great Abington",
"region": "UK",
"postalCode": "CB21 6AD",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "sme"
}
}
],
"buyer": {
"id": "GB-FTS-3022",
"name": "NHS England"
},
"language": "en",
"awards": [
{
"id": "018165-2022-1",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11905",
"name": "Octapharma Limited"
}
]
},
{
"id": "018165-2022-2",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11905",
"name": "Octapharma Limited"
}
]
},
{
"id": "018165-2022-3",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd"
}
]
},
{
"id": "018165-2022-4",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-5",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11905",
"name": "Octapharma Limited"
}
]
},
{
"id": "018165-2022-6",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd"
}
]
},
{
"id": "018165-2022-7",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57451",
"name": "LFB"
}
]
},
{
"id": "018165-2022-8",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-9",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-10",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd"
}
]
},
{
"id": "018165-2022-11",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57452",
"name": "Novo Nordisk"
}
]
},
{
"id": "018165-2022-12",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57453",
"name": "Bio Products Laboratory Ltd"
}
]
},
{
"id": "018165-2022-13",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57453",
"name": "Bio Products Laboratory Ltd"
}
]
},
{
"id": "018165-2022-14",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-15",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57451",
"name": "LFB"
}
]
},
{
"id": "018165-2022-16",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11905",
"name": "Octapharma Limited"
}
]
},
{
"id": "018165-2022-17",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd"
}
]
},
{
"id": "018165-2022-18",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-19",
"title": "Bleeding Disorders including Haemophilia B p",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57452",
"name": "Novo Nordisk"
}
]
},
{
"id": "018165-2022-20",
"title": "Bleeding Disorders including Haemophilia B p",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57451",
"name": "LFB"
}
]
},
{
"id": "018165-2022-21",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57454",
"name": "Pfizer Ltd"
}
]
},
{
"id": "018165-2022-22",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57450",
"name": "Takeda UK Ltd"
}
]
},
{
"id": "018165-2022-23",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57452",
"name": "Novo Nordisk"
}
]
},
{
"id": "018165-2022-24",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57449",
"name": "CSL Behring UK Ltd"
}
]
},
{
"id": "018165-2022-25",
"title": "Bleeding Disorders including Haemophilia B Lot 1 - eftrenonacog alfa (rFIX EHL)",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-57455",
"name": "Sobi (Swedish Orphan Biovitrum Ltd)"
}
]
}
],
"contracts": [
{
"id": "018165-2022-1",
"awardID": "018165-2022-1",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-2",
"awardID": "018165-2022-2",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-3",
"awardID": "018165-2022-3",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-4",
"awardID": "018165-2022-4",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-5",
"awardID": "018165-2022-5",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-6",
"awardID": "018165-2022-6",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-7",
"awardID": "018165-2022-7",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-8",
"awardID": "018165-2022-8",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-9",
"awardID": "018165-2022-9",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-10",
"awardID": "018165-2022-10",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-11",
"awardID": "018165-2022-11",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-12",
"awardID": "018165-2022-12",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-13",
"awardID": "018165-2022-13",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-14",
"awardID": "018165-2022-14",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-15",
"awardID": "018165-2022-15",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-16",
"awardID": "018165-2022-16",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-17",
"awardID": "018165-2022-17",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-18",
"awardID": "018165-2022-18",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-19",
"awardID": "018165-2022-19",
"title": "Bleeding Disorders including Haemophilia B p",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-20",
"awardID": "018165-2022-20",
"title": "Bleeding Disorders including Haemophilia B p",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-21",
"awardID": "018165-2022-21",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-22",
"awardID": "018165-2022-22",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-23",
"awardID": "018165-2022-23",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-24",
"awardID": "018165-2022-24",
"title": "Bleeding Disorders including Haemophilia B",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
},
{
"id": "018165-2022-25",
"awardID": "018165-2022-25",
"title": "Bleeding Disorders including Haemophilia B Lot 1 - eftrenonacog alfa (rFIX EHL)",
"status": "active",
"value": {
"amount": 1,
"currency": "GBP"
},
"dateSigned": "2022-06-15T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"value": 1
},
{
"id": "6",
"measure": "bids",
"value": 4
},
{
"id": "11",
"measure": "bids",
"value": 4
},
{
"id": "16",
"measure": "bids",
"value": 4
},
{
"id": "21",
"measure": "bids",
"value": 3
},
{
"id": "26",
"measure": "bids",
"value": 3
},
{
"id": "31",
"measure": "bids",
"value": 3
},
{
"id": "36",
"measure": "bids",
"value": 1
},
{
"id": "41",
"measure": "bids",
"value": 1
},
{
"id": "46",
"measure": "bids",
"value": 1
},
{
"id": "51",
"measure": "bids",
"value": 1
},
{
"id": "56",
"measure": "bids",
"value": 1
},
{
"id": "61",
"measure": "bids",
"value": 1
},
{
"id": "66",
"measure": "bids",
"value": 1
},
{
"id": "71",
"measure": "bids",
"value": 1
},
{
"id": "76",
"measure": "bids",
"value": 2
},
{
"id": "81",
"measure": "bids",
"value": 2
},
{
"id": "86",
"measure": "bids",
"value": 1
},
{
"id": "91",
"measure": "bids",
"value": 2
},
{
"id": "96",
"measure": "bids",
"value": 2
},
{
"id": "101",
"measure": "bids",
"value": 2
},
{
"id": "106",
"measure": "bids",
"value": 2
},
{
"id": "111",
"measure": "bids",
"value": 1
},
{
"id": "116",
"measure": "bids",
"value": 1
},
{
"id": "121",
"measure": "bids",
"value": 1
},
{
"id": "2",
"measure": "smeBids",
"value": 0
},
{
"id": "7",
"measure": "smeBids",
"value": 0
},
{
"id": "12",
"measure": "smeBids",
"value": 0
},
{
"id": "17",
"measure": "smeBids",
"value": 0
},
{
"id": "22",
"measure": "smeBids",
"value": 0
},
{
"id": "27",
"measure": "smeBids",
"value": 0
},
{
"id": "32",
"measure": "smeBids",
"value": 0
},
{
"id": "37",
"measure": "smeBids",
"value": 0
},
{
"id": "42",
"measure": "smeBids",
"value": 0
},
{
"id": "47",
"measure": "smeBids",
"value": 0
},
{
"id": "52",
"measure": "smeBids",
"value": 0
},
{
"id": "57",
"measure": "smeBids",
"value": 0
},
{
"id": "62",
"measure": "smeBids",
"value": 0
},
{
"id": "67",
"measure": "smeBids",
"value": 0
},
{
"id": "72",
"measure": "smeBids",
"value": 0
},
{
"id": "77",
"measure": "smeBids",
"value": 0
},
{
"id": "82",
"measure": "smeBids",
"value": 0
},
{
"id": "87",
"measure": "smeBids",
"value": 0
},
{
"id": "92",
"measure": "smeBids",
"value": 0
},
{
"id": "97",
"measure": "smeBids",
"value": 0
},
{
"id": "102",
"measure": "smeBids",
"value": 0
},
{
"id": "107",
"measure": "smeBids",
"value": 0
},
{
"id": "112",
"measure": "smeBids",
"value": 0
},
{
"id": "117",
"measure": "smeBids",
"value": 0
},
{
"id": "122",
"measure": "smeBids",
"value": 1
},
{
"id": "3",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "8",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "13",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "18",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "23",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "28",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "33",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "38",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "43",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "48",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "53",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "58",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "63",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "68",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "73",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "78",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "83",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "88",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "93",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "98",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "103",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "108",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "113",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "118",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "123",
"measure": "foreignBidsFromEU",
"value": 0
},
{
"id": "4",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "9",
"measure": "foreignBidsFromNonEU",
"value": 4
},
{
"id": "14",
"measure": "foreignBidsFromNonEU",
"value": 4
},
{
"id": "19",
"measure": "foreignBidsFromNonEU",
"value": 4
},
{
"id": "24",
"measure": "foreignBidsFromNonEU",
"value": 3
},
{
"id": "29",
"measure": "foreignBidsFromNonEU",
"value": 3
},
{
"id": "34",
"measure": "foreignBidsFromNonEU",
"value": 3
},
{
"id": "39",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "44",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "49",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "54",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "59",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "64",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "69",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "74",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "79",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "84",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "89",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "94",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "99",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "104",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "109",
"measure": "foreignBidsFromNonEU",
"value": 2
},
{
"id": "114",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "119",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "124",
"measure": "foreignBidsFromNonEU",
"value": 1
},
{
"id": "5",
"measure": "electronicBids",
"value": 1
},
{
"id": "10",
"measure": "electronicBids",
"value": 4
},
{
"id": "15",
"measure": "electronicBids",
"value": 4
},
{
"id": "20",
"measure": "electronicBids",
"value": 4
},
{
"id": "25",
"measure": "electronicBids",
"value": 3
},
{
"id": "30",
"measure": "electronicBids",
"value": 3
},
{
"id": "35",
"measure": "electronicBids",
"value": 3
},
{
"id": "40",
"measure": "electronicBids",
"value": 1
},
{
"id": "45",
"measure": "electronicBids",
"value": 1
},
{
"id": "50",
"measure": "electronicBids",
"value": 1
},
{
"id": "55",
"measure": "electronicBids",
"value": 1
},
{
"id": "60",
"measure": "electronicBids",
"value": 1
},
{
"id": "65",
"measure": "electronicBids",
"value": 1
},
{
"id": "70",
"measure": "electronicBids",
"value": 1
},
{
"id": "75",
"measure": "electronicBids",
"value": 1
},
{
"id": "80",
"measure": "electronicBids",
"value": 2
},
{
"id": "85",
"measure": "electronicBids",
"value": 2
},
{
"id": "90",
"measure": "electronicBids",
"value": 1
},
{
"id": "95",
"measure": "electronicBids",
"value": 2
},
{
"id": "100",
"measure": "electronicBids",
"value": 2
},
{
"id": "105",
"measure": "electronicBids",
"value": 2
},
{
"id": "110",
"measure": "electronicBids",
"value": 2
},
{
"id": "115",
"measure": "electronicBids",
"value": 1
},
{
"id": "120",
"measure": "electronicBids",
"value": 1
},
{
"id": "125",
"measure": "electronicBids",
"value": 1
}
]
}
}